Concepedia

Richard Ong

RO

Statistics

Publications

11

Citations

514

H-Index

11

Active since

2011

Affiliations

National Cancer Centre Singapore(Current)

Novartis (Switzerland)

Singapore General Hospital

Novartis (United States)

Bioinformatics Institute

Richard Ong is an author at National Cancer Centre Singapore specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2011–2020

11

Publications

11

FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors

Fang Li, Hung Huynh, Xiaoyan Li et al. · Cancer Discovery · 2015 · 105 citations · Full text

Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus

Hung Huynh, Huai-Xiang Hao, Stephen L. Chan et al. · Molecular Cancer Therapeutics · 2015 · 79 citations

, , +16

Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma

Hung Huynh, Liek Yeow Lee, Kah Yong Goh et al. · Hepatology · 2018 · 59 citations · Full text

Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma

Hung Huynh, Pierce K. H. Chow, Wai Ming Tai et al. · Journal of Hepatology · 2011 · 58 citations

, , +9

Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma

Hung Huynh, Richard Ong, Khee Chee Soo · Angiogenesis · 2011 · 57 citations

, , +8

1–5 of 11